FDA approves Lucemyra to treat symptoms of opioid withdrawal and help patients overcome addiction - News Summed Up

FDA approves Lucemyra to treat symptoms of opioid withdrawal and help patients overcome addiction


"The physical symptoms of opioid withdrawal can be one of the biggest barriers for patients seeking help and ultimately overcoming addiction," said Dr. Scot Gottlieb, the FDA's commissioner. "The fear of experiencing withdrawal symptoms often prevents those suffering from opioid addiction from seeking help. And those who seek assistance may relapse due to continued withdrawal symptoms."


Source: Los Angeles Times May 16, 2018 23:26 UTC


Loading...

Loading...